【24h】

MASTER REGULATORS USED AS BREAST CANCER METASTASIS CLASSIFIER

机译:主调节器用作乳腺癌转移分类器

获取原文
获取原文并翻译 | 示例

摘要

Computational identification of prognostic biomarkers capable of withstanding follow-up validation efforts is still an open challenge in cancer research. For instance, several gene expression profiles analysis methods have been developed to identify gene signatures that can classify cancer sub-phenotypes associated with poor prognosis. However, signatures originating from independent studies show only minimal overlap and perform poorly when classifying datasets other than the ones they were generated from. In this paper, we propose a computational systems biology approach that can infer robust prognostic markers by identifying upstream Master Regulators, causally related to the presentation of the phenotype of interest. Such a strategy effectively extends and complements other existing methods and may help further elucidate the molecular mechanisms of the observed pathophysiological phenotype. Results show that inferred regulators substantially outperform canonical gene signatures both on the original dataset and across distinct datasets.
机译:能够经受后续验证工作的预后生物标志物的计算鉴定仍然是癌症研究中的一个开放挑战。例如,已经开发了几种基因表达谱分析方法来鉴定可以对与不良预后相关的癌症亚表型进行分类的基因标记。但是,源自独立研究的签名仅显示了最小的重叠,并且在对除生成数据集以外的数据集进行分类时表现不佳。在本文中,我们提出了一种计算系统生物学方法,该方法可通过识别与目标表型的表达有因果关系的上游主调节剂来推断可靠的预后指标。这种策略有效地扩展和补充了其他现有方法,并可能有助于进一步阐明观察到的病理生理表型的分子机制。结果表明,无论是在原始数据集上还是在不同的数据集上,推断的调节子都大大胜过规范的基因签名。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号